Assay reproducibility in clinical studies of plasma miRNA.
There are increasing reports of plasma miRNAs as biomarkers of human disease but few standards in methodologic reporting, leading to inconsistent data. We systematically reviewed plasma miRNA studies published between July 2013-June 2014 to assess methodology. Six parameters were investigated: time...
Main Authors: | Jonathan Rice, Henry Roberts, James Burton, Jianmin Pan, Vanessa States, Shesh N Rai, Susan Galandiuk |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4390277?pdf=render |
Similar Items
-
miRNA expression profiles of premalignant and malignant arsenic-induced skin lesions.
by: Laila Al-Eryani, et al.
Published: (2018-01-01) -
Plasma Level of miRNA-7, miRNA-409 and miRNA-93 as Potential Biomarkers for Colorectal Cancer
by: Maryam Zare, et al.
Published: (2019-01-01) -
Statistical Issues and Group Classification in Plasma MicroRNA Studies With Data Application
by: Shesh N Rai, et al.
Published: (2020-04-01) -
Comparison of Reproducibility, Accuracy, Sensitivity, and Specificity of miRNA Quantification Platforms
by: Paula M. Godoy, et al.
Published: (2019-12-01) -
Integrative Analysis of miRNA-mRNA and miRNA-miRNA Interactions
by: Li Guo, et al.
Published: (2014-01-01)